- Home
- RANI vs HUIZ Comparison
RANI vs HUIZ Comparison
Compare RANI & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- HUIZ
- Stock Information
- Founded
- RANI 2012
- HUIZ 2006
- Country
- RANI United States
- HUIZ China
- Employees
- RANI N/A
- HUIZ N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- HUIZ Specialty Insurers
- Sector
- RANI Health Care
- HUIZ Finance
- Exchange
- RANI Nasdaq
- HUIZ Nasdaq
- Market Cap
- RANI 23.2M
- HUIZ 25.3M
- IPO Year
- RANI 2021
- HUIZ 2020
- Fundamental
- Price
- RANI $0.55
- HUIZ $2.27
- Analyst Decision
- RANI Strong Buy
- HUIZ Hold
- Analyst Count
- RANI 4
- HUIZ 1
- Target Price
- RANI $7.75
- HUIZ $2.30
- AVG Volume (30 Days)
- RANI 1.1M
- HUIZ 21.1K
- Earning Date
- RANI 08-07-2025
- HUIZ 09-24-2025
- Dividend Yield
- RANI N/A
- HUIZ N/A
- EPS Growth
- RANI N/A
- HUIZ N/A
- EPS
- RANI N/A
- HUIZ N/A
- Revenue
- RANI $1,200,000.00
- HUIZ $168,454,627.00
- Revenue This Year
- RANI N/A
- HUIZ $11.94
- Revenue Next Year
- RANI N/A
- HUIZ $8.15
- P/E Ratio
- RANI N/A
- HUIZ N/A
- Revenue Growth
- RANI N/A
- HUIZ 1.28
- 52 Week Low
- RANI $0.39
- HUIZ $1.50
- 52 Week High
- RANI $3.75
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- RANI 53.01
- HUIZ 45.92
- Support Level
- RANI $0.50
- HUIZ $2.15
- Resistance Level
- RANI $0.59
- HUIZ $2.67
- Average True Range (ATR)
- RANI 0.04
- HUIZ 0.26
- MACD
- RANI 0.00
- HUIZ -0.01
- Stochastic Oscillator
- RANI 63.16
- HUIZ 23.44
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.